InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (740 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
740
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the full record of transactions filed by Rothblatt Martine A, Founder, Chairperson, and Chief Executive Officer. Officer active across 2 companies, notably UNITED THERAPEUTICS Corp. Aggregated, 1,023 disclosures have been logged. Breakdown: 0 buy · 740 sells. Total volume traded: €286.7m. Activity tracked since 10 September 2021. The latest transaction was filed on 23 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rothblatt Martine A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones1023 en total
200 títulos@ 524,4175 US$0.0005% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000131:11
9500 títulos@ 135,42 US$0.0058% mcap0.2% de su flujoCommon StockSEC:0001106578-26-000131:0
480 títulos@ 514,257 US$0.0011% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000131:1
1630 títulos@ 515,4587 US$0.0038% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000131:2
2386 títulos@ 516,1571 US$0.0055% mcap0.2% de su flujoCommon StockSEC:0001106578-26-000131:3
1486 títulos@ 517,1073 US$0.0035% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000131:4
1346 títulos@ 518,1434 US$0.0031% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000131:5
412 títulos@ 519,1925 US$0.0010% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000131:6
751 títulos@ 520,2975 US$0.0018% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000131:7
286 títulos@ 521,5815 US$0.0007% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000131:8
517 títulos@ 522,4022 US$0.0012% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000131:9
6 títulos@ 523,425 US$0.0000% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000131:10
9500 títulos@ 135,42 US$0.0058% mcap0.2% de su flujoCommon StockSEC:0001106578-26-000130:0
704 títulos@ 513,4012 US$0.0016% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000130:3
120 títulos@ 514,3201 US$0.0003% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:4
240 títulos@ 515,3299 US$0.0006% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:5
280 títulos@ 517,0703 US$0.0007% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:6
642 títulos@ 512,4714 US$0.0015% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000130:2
120 títulos@ 531,12 US$0.0003% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:18
494 títulos@ 511,5751 US$0.0011% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:1
200 títulos@ 518,894 US$0.0005% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:7
1003 títulos@ 520,234 US$0.0024% mcap0.1% de su flujoCommon StockSEC:0001106578-26-000130:8
477 títulos@ 521,2356 US$0.0011% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:9
280 títulos@ 522,4029 US$0.0007% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:10
240 títulos@ 523,60 US$0.0006% mcap0.0% de su flujoCommon StockSEC:0001106578-26-000130:11
25 de 1023 declaraciones
About Rothblatt Martine A
ROTHBLATT MARTINE A is Founder, Chairperson, and Chief Executive Officer, and also serves as Chairperson & CEO at UNITED THERAPEUTICS Corp and as Director at BETA Technologies, Inc. Across 598 filings in total, the 400 most recent filings cover the period from 2025-10-01 to 2026-07-09 and show only sales, for EUR 131333628; the listed filings are the 2026-05-01 filing at UNITED THERAPEUTICS Corp for EUR 1864504.520765315, the 2026-04-16 filing for EUR 1808146.280524264, the 2026-04-24 filing for EUR 1807397.69118175, the 2026-07-08 filing for EUR 1662326.708495125, the 2026-07-07 filing for EUR 1609987.382414076, and the 2026-04-27 filing for EUR 1558095.834488173.
